136 related articles for article (PubMed ID: 33575871)
1. ASO Author Reflections: Rectosigmoid Mesorectal Sparing Resection: A Feasible Technique and a Viable Option in Advanced Ovarian Cancer Surgery.
Rosati A; Vargiu V; Santullo F; Lodoli C; Attalla El Halabieh M; Scambia G; Fagotti A; Costantini B
Ann Surg Oncol; 2021 Oct; 28(11):6723-6724. PubMed ID: 33575871
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Total Parietal Peritonectomy During Interval Cytoreductive Surgery for Advanced Ovarian Cancer-Proof-of-Principle and Analysis of Morbidity.
Bhatt A; Kammar P; Mehta S; Sinukumar S
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):861-862. PubMed ID: 32720047
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery-What We Know and Future Perspectives.
Vargiu V; Santullo F; Rosati A; Costantini B; Gallotta V; Lodoli C; Pacelli F; Scambia G; Fagotti A
Ann Surg Oncol; 2022 Aug; 29(8):4803-4804. PubMed ID: 35430663
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Personalized Surgery in Recurrent Ovarian Cancer Patients.
Estati FL; Baiocchi G; da Costa AABA
Ann Surg Oncol; 2021 Jul; 28(7):3646-3647. PubMed ID: 33211231
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer.
Marchetti C; Fagotti A; Scambia G; De Felice F
Ann Surg Oncol; 2021 Jun; 28(6):3264-3265. PubMed ID: 33123859
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: The PlasmaJet
Nieuwenhuyzen-de Boer GM; van Beekhuizen HJ
Ann Surg Oncol; 2022 Aug; 29(8):4844-4845. PubMed ID: 35482266
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Surgery and Bevacizumab in Ovarian Cancer.
Petrillo M; Scambia G; Fagotti A
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):886-887. PubMed ID: 30414040
[No Abstract] [Full Text] [Related]
8. Rectosigmoid Mesorectal-Sparing Resection in Advanced Ovarian Cancer Surgery.
Rosati A; Vargiu V; Santullo F; Lodoli C; Attalla El Halabieh M; Scambia G; Fagotti A; Costantini B
Ann Surg Oncol; 2021 Oct; 28(11):6721-6722. PubMed ID: 33586073
[TBL] [Abstract][Full Text] [Related]
9. ASO Author Reflections: Value of Cytoreduction in Extensive Ovarian Cancer-Does Surgical Effort Still Matter?
Fotopoulou C
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):786-787. PubMed ID: 31605337
[No Abstract] [Full Text] [Related]
10. Comparison of posterior rectal dissection techniques during rectosigmoid colon resection as part of cytoreductive surgery in patients with epithelial ovarian cancer: Close rectal dissection versus total mesorectal excision.
Son JH; Kim J; Shim J; Kong TW; Paek J; Chang SJ; Ryu HS
Gynecol Oncol; 2019 May; 153(2):362-367. PubMed ID: 30846223
[TBL] [Abstract][Full Text] [Related]
11. En bloc pelvic resection for ovarian carcinomatosis: Hudson procedure in 10 steps.
Angeles MA; Martínez-Gómez C; Martinez A; Ferron G
Gynecol Oncol; 2019 Apr; 153(1):209-210. PubMed ID: 30558973
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: HIPEC with Cisplatin Improves Prognosis in Advanced Ovarian Cancer after Neoadjuvant Chemotherapy.
Cascales Campos PA; González Gil A
Ann Surg Oncol; 2022 Apr; 29(4):2626-2627. PubMed ID: 34977982
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Redefining Consolidation Cytoreductive Surgery for Ovarian Cancer.
Bhatt A; Alcazer V; Frankinet L; Bakrin N; Glehen O
Ann Surg Oncol; 2023 Jun; 30(6):3300-3301. PubMed ID: 36808321
[No Abstract] [Full Text] [Related]
14. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
[TBL] [Abstract][Full Text] [Related]
15. Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer.
Bartl T; Schwameis R; Stift A; Bachleitner-Hofmann T; Reinthaller A; Grimm C; Polterauer S
Int J Gynecol Cancer; 2018 Nov; 28(9):1664-1671. PubMed ID: 30371563
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and rationale of a novel approach in advanced ovarian cancer surgery: Bat- shaped en-bloc total peritonectomy and total hysterectomy salpingo-oophorectomy with or without rectosigmoid resection (Sarta-Bat approach).
Khatib G; Seyfettinoglu S; Guzel AB; Gulec UK; Unlugenc H; Vardar MA
Gynecol Oncol; 2021 Apr; 161(1):97-103. PubMed ID: 33234261
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic Resection as Part of Cytoreductive Surgery in Advanced-stage and Recurrent Epithelial Ovarian Cancer--A Single-center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Jul; 35(7):4125-9. PubMed ID: 26124365
[TBL] [Abstract][Full Text] [Related]
18. ASO Author Reflections: Minimally Invasive Secondary Cytoreductive Surgery for Ovarian Cancer Lymph Node Recurrence: Shaping Treatment with All Arrows in our Quiver.
Loverro M; Ergasti R; Conte C; Gallitelli V; Nachira D; Scaglione G; Fagotti A; Scambia G; Gallotta V
Ann Surg Oncol; 2022 Apr; 29(4):2605-2606. PubMed ID: 35066718
[No Abstract] [Full Text] [Related]
19. Unanticipated 30-day readmission following rectosigmoid resection at the time of cytoreductive surgery in patients with advanced stage ovarian cancer.
Sanders BE; Saharti S; Laus K; Bristow RE; Eskander RN
J Obstet Gynaecol; 2021 Aug; 41(6):956-961. PubMed ID: 33228421
[TBL] [Abstract][Full Text] [Related]
20. Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer.
Plotti F; Montera R; Aloisi A; Scaletta G; Capriglione S; Luvero D; De Cicco Nardone C; Basile S; Benedetti Panici P; Angioli R
Eur J Surg Oncol; 2016 Mar; 42(3):383-90. PubMed ID: 26725211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
